Clinical Trials Logo

Ejaculation clinical trials

View clinical trials related to Ejaculation.

Filter by:

NCT ID: NCT02918227 Terminated - Clinical trials for Benign Prostatic Hyperplasia

Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia

EMMECH
Start date: December 8, 2016
Phase: N/A
Study type: Interventional

Every year in France, more than 60 000 people are operated for benign prostatic hyperplasia (BPH). This surgery is accompanied by a change or even a loss of ejaculations externalized what constitutes the main constraint for patients. Empirically, the investigators talk to the patient "retrograde ejaculation" to explain a possible loss of ejaculation. Yet the underlying mechanism of this modification or loss of ejaculation remains completely unknown. Yet the underlying mechanism of this modification or loss of ejaculation remains completely unknown. No study could not determine whether the predominant mechanism was a real retrograde ejaculation or aspermia. Moreover, technical changes are sometimes tempted to preserve antegrade ejaculation but no scientific rationale can not validate.

NCT ID: NCT01366664 Completed - Ejaculation Clinical Trials

A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin

Start date: April 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the pharmacodynamics (the actions or effects a drug has on the body), pharmacokinetics (blood levels), safety, and tolerability of dapoxetine 60 mg when concomitantly administered in participants taking terazosin.

NCT ID: NCT01230762 Completed - Clinical trials for Erectile Dysfunction

An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the long-term safety of dapoxetine in men with rapid ejaculation.

NCT ID: NCT01021670 Completed - Clinical trials for Sexual Dysfunction, Physiological

An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride

Start date: September 2009
Phase: Phase 4
Study type: Observational

The purpose of the study is to collect information regarding the safety of dapoxetine hydrochloride when used in clinical practice to treat men with premature ejaculation. Dapoxetine hydrochloride is a selective inhibitor of serotonin reuptake that is indicated for the treatment of patients with premature ejaculation.

NCT ID: NCT00219635 Completed - Ejaculation Clinical Trials

Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation

Start date: January 2005
Phase: Phase 2/Phase 3
Study type: Interventional

Assessment of efficacy and safety UK-390,957

NCT ID: NCT00219609 Completed - Ejaculation Clinical Trials

Assessment Of Safety Of UK-390,957

Start date: January 2005
Phase: Phase 2/Phase 3
Study type: Interventional

To determine whether UK-390,957 is a safe treatment for premature ejaculation.

NCT ID: NCT00219583 Completed - Ejaculation Clinical Trials

Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation

Start date: August 2004
Phase: Phase 2/Phase 3
Study type: Interventional

Assessment of efficacy and safety UK-390,957.

NCT ID: NCT00211107 Completed - Ejaculation Clinical Trials

A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.

Start date: June 2003
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to demonstrate that dapoxetine can prolong intravaginal ejaculatory latency time (IELT) compared with placebo in men with premature ejaculation (PE).

NCT ID: NCT00211094 Completed - Ejaculation Clinical Trials

A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation

Start date: n/a
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to demonstrate that dapoxetine can prolong intravaginal ejaculatory latency time (IELT) compared with placebo in men with premature ejaculation (PE).

NCT ID: NCT00210613 Completed - Sexual Dysfunction Clinical Trials

A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation

Start date: November 2004
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to assess the possible withdrawal effects after abruptly stopping daily therapy with dapoxetine compared with continuing daily therapy in men with premature ejaculation (PE).